Alembic Pharmaceuticals Q2 Results

  • BSE: 533573
  • NSE: APLLTD
  • ISIN: INE901L01018
  • Sector: Biotechnology & Drugs
BSE
953.8-6.90 (-0.72%)
Volume3.00 K
Updated: Fri 24 May, 2024 | 15:29:46
NSE
949.95-10.60 (-1.10%)
Volume58.81 K
Updated: Fri 24 May, 2024 | 15:32:53
Today: 944.05
963.40
52-Wk: 536.60
1,093.05

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Alembic Pharmaceuticals Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 1,594.931,486.157.32%
    Selling/ General/ Admin Expenses Total 346.99348.17-0.34%
    Depreciation/ Amortization 67.5666.182.09%
    Other Operating Expenses Total 578.26525.789.98%
    Total Operating Expense 1,454.241,353.657.43%
    Operating Income 140.69132.506.18%
    Net Income Before Taxes 135.15129.784.14%
    Net Income 136.56120.6013.23%
    Diluted Normalized EPS 6.956.1413.19%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App